GAD2 and Alzheimer disease: A recent meta-analysis reported that patients with AD display lower GABA levels in their brain and cerebrospinal fluid, and GAD65/67, GABAA receptors, and GABA transporters were also lower in the AD brains (Carello-Collar et al., 2023).